3Jeong H S,Shin J H,Park Y N. Development of real-time RT-PCR for evaluation of JEV clearance during purification of HPV type 16L1 virus-like particlea[J].Biological,2003,(03):223-229.
4NAM J H,WYATT L S,CHAE S L,et al.Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes[J]. Vaccine, 1999,17(3) : 261-268.
5XU X G, WANG Z S, ZHANG Q, et al.Bacuiovirus surface display of E envelope glycoprotein of Japanese encephalitis virus and its immunogenicity of the displayed proteins in mouse and swine models[J]. Vaccine, 2011,29(4) :636-643.
6CHEN H W, PAN C H, LIAU M Y, et al.Scmening of protective antigens of Japanese encephalitis virus by DNA immunization :a comparative study with conventional viral vaccines[J].J Virol, 1999,73(12). 10137-10145.
7KONISHI E,YAMAOKA M, KHIN SANE W,et al.Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding Japanese encephalitis virus premembrane and envelope genes[J]. J Virol, 1998,72(6):4925-4930.
8TORRESI J, MC eARTHY K, FEROLDI E, et al. Immunogenicity, safety, and tolerability in adults of a new single - dose, live attenuated vaccine against Japanese encephalitis, randomised controlled Phase 3 trials [J]. Vaccine,2010,28(50): 7993-8000.
9FISCHER M, LINDSEY N, STAPLES J E, et al. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practice(ACIP) [J]. MMWR Recomm Rep, 2010,59:1-27.
10KONISHI E, PINCUS S, PAOLETTI E, et al, Avipox virus-vectored Japanese encephalitisvirus vaccines: use as vaccine candidates in combination with purified subunit immunogens[J]. Vaccine, 1994(12): 633-638.
